CNSP Archives - TinyGems

TuesdaySep 08, 2026 10:00 am

Laser Therapy Shows Promise in Treating Brain Cancer

Researchers from the Washington University School of Medicine in St. Louis have found a way to improve brain cancer treatment: laser therapy. This technology has played an increasingly larger role in brain cancer therapy over the past 15 years as an alternative to open skull surgery. The research team has spent years studying a technique called laser interstitial thermal therapy, or LITT, to improve the overall treatment experience and outcomes for brain cancer patients. The procedure works by guiding a slim, machine-controlled probe through a narrow, drilled opening and monitoring its path on live imaging to avoid tissue it shouldn't touch. Once positioned, the tip then…

MondayAug 24, 2026 10:00 am

New T Cell Therapy Could Transform Glioblastoma Care

Recurrent glioblastoma leaves patients with almost no effective treatments to fall back on. Standard therapies typically combine surgery with chemotherapy, but the disease usually comes back in a harsher, harder-to-treat form. Median survival after recurrence is less than a year. A new Phase I trial published August 6 in the journal Nature Medicine suggests an experimental immunotherapy may finally offer these patients another option. The treatment relies on CAR-T cell therapy, an approach that re-engineers a patient's own immune cells to hunt down cancer. Researchers trained the modified cells, known as CAR-T cells, to target B7-H3, a protein found on the surface of most glioblastomas but largely absent from healthy tissue. Scientists…

MondayJul 13, 2026 10:00 am

Widely Prescribed Thyroid Hormone Could Prevent Pediatric Brain Tumor Recurrence

A research team investigating children's brain tumors has found promising results combining a hormone treatment with standard chemotherapy protocols. Triiodothyronine, commonly called T3, is a medication long used to manage thyroid disorders in patients throughout the lifespan. The hormone showed enhanced effectiveness when added to conventional cancer therapy in laboratory studies and animal models. A clinical trial is now recruiting pediatric patients to test whether this combined approach works in actual clinical settings. Medulloblastoma accounts for the leading category of malignant pediatric brain cancers, striking hundreds of young children annually. Treatment currently requires aggressive intervention that combines surgical removal with systemic therapy and radiation.…

WednesdayApr 15, 2026 10:00 am

Scientists Discover Brain Cells That Aid Brain Cancer Development

Canadian scientists have made an unexpected finding about glioblastoma, one of the deadliest and hardest-to-treat forms of brain cancer. Cells previously regarded as passive support structures in healthy brain tissue have been found to actively fuel tumor growth through signaling that boosts cancer cell function. The discovery also points toward a drug already in wide clinical use that may be capable of interrupting that process. Both findings represent meaningful advances in a field that has seen very limited therapeutic progress over several decades. Glioblastoma carries one of oncology's bleakest prognoses, with survival following diagnosis typically measured in months rather than years. Patients have access to very few effective treatment…

MondayMar 23, 2026 10:00 am

Fewer Men Undergo Cancer Screening, Study Shows

Men make up just 5% of people getting genetic tests for inherited cancer risks despite dying from cancer at higher rates than women, new research shows. Analysis of more than 224,000 tests revealed men who do get screened face much higher odds of carrying dangerous genetic mutations, with positive results hitting 14% versus 8% for women. The gap represents a major blind spot in cancer prevention. Genetic screening spots inherited vulnerabilities to breast, ovarian, prostate, and colon cancers, letting doctors track high-risk patients and step in early. Women benefit from widespread protocols urging doctors to evaluate hereditary breast and ovarian cancer factors during routine care. Similar systems cover other…

WednesdayFeb 18, 2026 10:00 am

Pressure from Brain Tumors Triggers Self-Destruct Mechanism in Neurons, Study Finds

Brain tumors may damage surrounding tissue in a more insidious way than previously understood. New research from the University of Notre Dame shows that chronic pressure from an expanding tumor does not simply crush nearby neurons. It activates an internal self-destruction program that pushes those cells toward death. Neurons form the backbone of thought, movement and sensation. When they die, the brain cannot easily replace them. That loss often leads to cognitive decline, motor impairment and sensory deficits seen in patients with aggressive brain cancers and traumatic injuries. An interdisciplinary team at the University of Notre Dame set out to examine how mechanical compression alone affects healthy brain cells. Meenal Datta, a professor of aerospace and mechanical engineering…

WednesdayDec 10, 2025 10:00 am

Optimal Treatment Timing Could Boost Cancer Therapy Efficacy

Administering chemotherapy at specific times could significantly improve outcomes for brain cancer patients. Washington University in St. Louis researchers discovered that treatment timing plays a crucial role in how effectively glioblastoma patients respond to standard drug protocols. Funding came from NCI, Siteman Cancer Center, and National Institutes of Health, with the cancer center operating at WashU Medicine and Barnes-Jewish Hospital. Examining glioblastoma's resistance to treatment despite affecting hundreds of thousands annually, the findings were published in the Journal of Neuro-Oncology. While Temozolomide remains the go-to chemotherapy compound for this malignancy, many patients see limited benefits. Cancer cells typically activate MGMT,…

MondayNov 10, 2025 10:00 am

New Implants Defy Necessity of Brain Surgery Against Cancer

Microscopic wireless electronics that self-navigate to diseased brain tissue could eliminate the need for surgery when treating tumors and neurological conditions. Massachusetts Institute of Technology researchers demonstrated the technology in mice, showing how tiny devices injected into the bloodstream can autonomously locate target regions and deliver electrical stimulation without human guidance. These implants are fused with immune cells before injection, allowing them to slip past the body's defenses and cross the blood-brain barrier intact. Each device measures roughly one-billionth of a rice grain's length, built from layered organic semiconducting polymers positioned between metallic components to create an electronic structure. Scientists…

MondayOct 27, 2025 10:00 am

Scientists Uncover Possible Driver of ‘Chemo Brain’

A recent study has found that the cognitive difficulties which cancer patients experience during and after treatment could stem from chemotherapy-induced damage to the brain's waste drainage network. Newly discovered evidence sheds light on a widespread yet poorly understood phenomenon that affects up to 75% of individuals undergoing cancer therapy, chemo brain. The symptoms associated with this condition, including memory lapses and problems with concentration and finding words, typically persist long after treatment is complete. Published in the journal Communications Biology, the study examined how common cancer drugs impact meningeal lymphatics, specialized vessels within the brain membranes responsible for waste…

MondayOct 13, 2025 10:00 am

New AI Tool Boosts Precision Medicine in Treating CNS Cancers

Harvard Medical School researchers have developed an AI system that distinguishes glioblastoma from other brain tumors during surgery. The tool called PICTURE achieved 99.8% accuracy in differentiating glioblastoma from primary central nervous system lymphoma. This rare malignancy is frequently misdiagnosed as glioblastoma, yet the AI system outperformed nine human neuropathologists who misclassified lymphoma as glioblastoma in 38% of test cases. With over 100 distinct subtypes, central nervous system tumors involve exceptional diagnostic complexity. Glioblastoma represents the most common variety, with patients typically receiving surgical tumor removal but facing a median survival of just eight months. Primary CNS lymphoma shares overlapping…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Tag: CNSP